DCM
ABMD

Driehaus Capital Management’s Abiomed Inc ABMD Stock Holding History

Driehaus Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,021
Closed -$2.71M – 543
2018
Q3 		$2.71M Sell
6,021
-4,332
-42% -$1.71M 0.08% 257
2018
Q2 		$4.24M Buy
10,353
+4,299
+71% +$1.56M 0.14% 193
2018
Q1 		$1.76M Buy
6,054
+41
+0.7% +$10.4K 0.06% 278
2017
Q4 		$1.13M Buy
6,013
+1,170
+24% +$218K 0.04% 326
2017
Q3 		$817K Sell
4,843
-3,240
-40% -$490K 0.03% 341
2017
Q2 		$1.16M Buy
8,083
+1,686
+26% +$227K 0.04% 323
2017
Q1 		$801K Sell
6,397
-288
-4% -$33.4K 0.03% 388
2016
Q4 		$753K Sell
6,685
-34,500
-84% -$4M 0.03% 381
2016
Q3 		$5.3M Sell
41,185
-6,323
-13% -$757K 0.18% 118
2016
Q2 		$5.19M Buy
47,508
+3,499
+8% +$348K 0.19% 127
2016
Q1 		$4.17M Buy
44,009
+5,742
+15% +$485K 0.14% 150
2015
Q4 		$3.46M Buy
38,267
+5,078
+15% +$431K 0.12% 204
2015
Q3 		$3.08M Sell
33,189
-2,858
-8% -$252K 0.11% 204
2015
Q2 		$2.37M Buy
36,047
+6,047
+20% +$402K 0.08% 313
2015
Q1 		$2.15M Buy
+30,000
New +$1.63M 0.07% 319

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Driehaus Capital Management's ABMD Position: Q4 2018 in Review

Driehaus Capital Management sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 6,021 shares — an estimated $2.71M sold.

Driehaus Capital Management first reported a position in ABMD in Q1 2015 and held it in 15 quarters. The position peaked at $5.3M in Q3 2016. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

  • Driehaus Capital Management reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
  • Driehaus Capital Management sold 6,021 Abiomed Inc shares in Q4 2018, an estimated $2.71M.
  • Driehaus Capital Management first reported a position in Abiomed Inc in Q1 2015 and held it in 15 quarters.
  • Driehaus Capital Management's Abiomed Inc position peaked at $5.3M in Q3 2016.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Driehaus Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.